Journals / Journal of Emergency Medicine Case Reports / 2026 / Cilt: 4 Sayı: 1

Successful Treatment of Valproic Acid Intoxication with Hemodialysis and L-Carnitine

Hemodiyaliz ve L-Carnitine ile Valproik Asit Zehirlenmesinin Başarılı Tedavisi

Tuğba Atmaca Temrel(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Seval İzdeş(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Gülhan Kurtoğlu Çelik(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Defne Altınbaş(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Havva Şahin Kavaklı(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Asliddin Ahmedali(Clinic of Emergency Medicine, Atatürk Training and Research Hospital, Ankara, Turkey)
Pages
10–12
Publication Date
2013-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present the case of a 31 year old female with VPA intoxication who was successfully treated with hemodialysis and L-carnitine, and a review of the literature on the management of VPA overdose

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valproic acid (VPA) is a conventional antiepileptic drug and, in parallel to its widespread prescription, it has been used in many cases of suicide attempts.
📊
Key Findings & Data:VPA intoxication may cause electrolyte disturbances, hepatotoxicity, pancreatitis, bone marrow suppression, and brain edema.
💡
Conclusion & Impact:We present the case of a 31 year old female with VPA intoxication who was successfully treated with hemodialysis and L-carnitine, and a review of the literature on the management of VPA overdose
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Valproik asit · karnitin · hemodiyaliz

Abstract

Valproic acid (VPA) is a conventional antiepileptic drug and, in parallel to its widespread prescription, it has been used in many cases of suicide attempts. VPA intoxication may cause electrolyte disturbances, hepatotoxicity, pancreatitis, bone marrow suppression, and brain edema. However, there is no specific antidote for treatment of VPA overdose. Case reports describe the efficacy of naloxone, L-carnitine and various extracorporeal elimination techniques in the treatment of VPA toxicity. We present the case of a 31 year old female with VPA intoxication who was successfully treated with hemodialysis and L-carnitine, and a review of the literature on the management of VPA overdose

Özet

Valproik asit (VPA) geniş spektrumlu bir antiepileptiktir, bu nedenle yaygın olarak kullanılması özkıyım vakalarında sık karşılaşılmasına yol açmıştır. VPA toksisitesinde elektrolit bozuklukları, hepatotoksisite, pankreatit, kemik iliği süpresyonu, beyin ödemi görülebilir. Ancak, VPA doz aşımı tedavisi için spesifik bir antidot yoktur. Olgu sunumları naloxone, L-karnitin ve çeşitli extrakorporeal eliminasyon tekniklerininVPA toksisitesinde etkinliğini açıklamaktadır. Biz 31 yaşında VPA intoksikasyonu bayan olgunun hemodiyaliz ve L karnitin ile başarılı tedavisini ve VPA toksisitesine yaklaşımın literatürünün gözden geçirilmesini burada sunuyoruz.

🔖

Cite This Article

Temrel, T. A., İzdeş, S., Çelik, G. K., Altınbaş, D., Kavaklı, H. Ş., Ahmedali, A. (2013). Successful Treatment of Valproic Acid Intoxication with Hemodialysis and L-Carnitine. Journal of Emergency Medicine Case Reports, Cilt: 4 Sayı: 1, 10–12. https://ajindex.com/articles/1346093

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid- induced toxicity. Clin Toxicol (Phila) 2009; 47: 101-11. [CrossRef]
  2. Mirski M. Anticonvulsants in the intensive care unit. In Textbook of Criti- cal Care. 5th Edition. Ed. Fink MP, Abraham E, Vincent JL, Kochanek P; Elsevier Saunders, 2005. p.1607-19.
  3. Aaron CK. Anticonvulsants. In Irwin and Rippe’s Intensive Care Medi- cine.(5th Edition). Eds Irwin RS, Rippe JM. Lippincott Williams and Wilkins; 2003.p.1383-92.
  4. Van der Wouden EA, Dekkers A, Kruis HM, van Geijlswijk IM, Tjan DH, Feith GW. Extracorporeal elimination in acute valproate intoxication. BMJ Case Rep 2009.
  5. Jung J, Eo E, Ahn KO. A case of hemoperfusion and L-carnitine manage- ment in valproic acid overdose.Am J Emerg Med 2008; 26: 388.
  6. Minville V, Roche Tissot C, Samii K. Haemodialysis, L-carnitine therapy and valproic acid overdose. Ann Fr Anesth Reanim 2004; 23: 357-60. [CrossRef]
  7. Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm 2012; 69: 35-9. [CrossRef]
  8. Perrott J, Murphy NG, Zed PJ. L-carnitine for acute valproic acid over- dose: a systematic review of published cases. Ann Pharmacother 2010; 44: 1287-93. [CrossRef]